Supreme Court Preserves Access to Key Abortion Drug, For Now

KQED's Forum

KQED

News Commentary, News, Politics

4.2 • 727 Ratings

🗓️ 24 April 2023

⏱️ 56 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

When the Supreme Court overturned Roe v. Wade last year, Justice Samuel Alito wrote that “the authority to regulate abortion is returned to the people and their elected representatives.” But less than a year later, the Supreme Court found itself needing to weigh in on medication abortion access. It decided on Friday to preserve access to mifepristone, a gold standard abortion drug, while lower courts sort out challenges to the FDA’s approval of the drug. We’ll examine where medication abortion access currently stands and what its future could look like. Guests: Shefali Luthra, health reporter covering the intersection of gender and health care, The 19th - an independent, nonprofit newsroom reporting on gender, politics and policy Mary Ziegler, professor of law, UC Davis; author, "Dollars for Life: The Anti-Abortion Movement and the Fall of the Republican Establishment" Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Support for Key QBD Podcasts comes from San Francisco International Airport. At SFO, you can shop,
0:06.7	dine, and unwind before your flight. Go ahead, treat yourself. Learn more about SFO restaurants and
0:12.7	shops at flysfo.com. Support for forum comes from Broadway SF, presenting Parade, the musical revival based on a true story.
0:23.4	From three-time Tony-winning composer Jason Robert Brown comes the story of Leo and Lucille Frank,
0:29.6	a newlywed Jewish couple struggling to make a life in Georgia. When Leo is accused of an
0:35.3	unspeakable crime, it propels them into an unimaginable test of faith, humanity, justice, and devotion.
0:43.4	The riveting and gloriously hopeful parade plays the Orpheum Theater for three weeks only, May 20th through June 8th.
0:51.7	Tickets on sale now at Broadway, sf.com. From KGB in San Francisco, I'm Mina Kim.
1:16.8	Coming up on form, the U.S. Supreme Court on Friday said the abortion pill Mithapristone
1:21.9	would remain available while a case challenging it moves through the lower courts.
1:26.5	But the legal fight against the FDA's approval of Mithopristone is moving fast
1:31.3	and could end up before the Supreme Court that overturned Roe v. Wade.
1:36.3	We take a closer look this hour at what's next for the medication that's commonly used to end early pregnancies or treat miscarriages.
1:43.3	What's next for other FDA-approved treatments, depending on how the case goes?
1:48.6	And where abortion access now stands.
1:50.7	Join us after this news.
1:59.6	Welcome to Forum. I'm Mina Kim. Advocates for reproductive rights say the fight for abortion access or safe miscarriage treatment is far from over, even after the U.S. Supreme Court said Friday that the abortion pill Miffa Pristone would remain available in states where it's legal as a challenge to the drug moves through the courts.
2:19.1	We take a closer look this hour at what's happened since a Texas judge this month attempted to revoke the FDA's approval of Mithapristone
2:26.5	and the prospects for abortion access in California and the nation.
2:31.5	Joining us is Shafali Luthera, health reporter covering the intersection of gender and
2:35.3	health care for the 19th and independent nonprofit newsroom reporting on gender, politics, and policy.
2:41.7	Sheffali, thanks so much for being with us. Thank you for having me. Mary Ziegler is also with
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from KQED, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of KQED and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.